Lumithera: Photobiomodulation Preclinical Mechanisms to Clinical Application: US Pivotal LIGHTSITE III Trial Results in Intermediate dry AMD Patients

Time & Date: 1 September, 13.15 – 14.15 CEST
Chairperson(s): M. Munk AUSTRIA

Speakers:

Presentations:

Speakers & Presentations:

K. Valter-Kocsi AUSTRALIA

Preclinical Mechanisms of Photobiomodulation

C. Tedford USA

Pivotal LIGHTSITE III Clinical Trial Results

M. Munk AUSTRIA

Clinical Trial Patient Imaging Results

Meet the Keynote Speakers

Secretariat Address
European Society of Retina Specialists
Reinacherstrasse 131
4053 Basel
Switzerland

T +41 61 686 77 91
F +41 61 686 77 88

Newsletter Sign up